Magnetic resonance imaging in the monitoring of disease progression in multiple sclerosis

Multiple Sclerosis

Volumn 5, Issue 4, 1999, Pages 268-272

  Stevenson, V L ^a   Miller, D H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

CONFERENCE PAPER; DISABILITY; DISEASE ACTIVITY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE;

EID: 0032837057     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859900500413     Document Type: Conference Paper

References (49)

1. Runmarker B, Andersen O. (1993) Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 116: 117-134.
2. Thompson AJ et al. (1997) Primary progressive multiple sclerosis. Brain 120: 1085-1096.
3. Losseff NA et al. (1996) Clinical and magnetic resonance imaging predictors of disability in primary and secondary progressive multiple sclerosis. Multiple Sclerosis 1: 218-222.
4. Paty DW, McFarland H. (1998) Magnetic resonance techniques to monitor the long term evolution of multiple sclerosis pathology and to monitor clinical trials. J Neurol Neurosurg Psychiatry 64: S47-S51.
5. Thompson AJ, Hobart J. (1998) Multiple sclerosis: assessment of disability and disability scales. J Neurol 245: 189-196.
6. IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group. (1995) Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45: 1277-1285.
7. Simon JH et al. (1998) Magnetic resonance studies of intramuscular interferon β-1a for relapsing multiple sclerosis. Ann Neurol 43: 79-87.
8. Paty DW et al. (1994) Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis. Ann Neurol 36: S95-S96.
9. Miller DH et al. (1998) A double-blind, placebo-controlled trial of Interferon beta-1b in secondary progressive multiple sclerosis: magnetic resonance imaging results. Ann Neurol 44: 503-504.
10. Molyneux PD et al. (1998) Precision and reliability for measurement of change in MRI lesion volume in multiple I sclerosis: a comparison of two computer assisted techniques. J Neurol Neurosurg Psychiatry 65: 42-47.
11. Filippi M et al. (1997) Interscanner variation in brain MRI lesion load measurements in MS: implications for clinical trials. J Neurol Neurosurg Psychiatry 49: 371-377.
12. Gawne-Cain ML, Webb S, Tofts P, Miller DH. (1996) Lesion volume measurement in multiple sclerosis: how important is repositioning? JMRI 6: 705-713.
13. Filippi M et al. (1995) Intra- and inter-observer agreement of brain MRI lesion volume measurements in multiple sclerosis. A comparison of techniques. Brain 118: 1593-1600.
14. Molyneux PD et al. (1998) The effect of slice thickness on magnetic resonance lesion detection and quantification in multiple sclerosis. AJNR 19: 1715-1720.
15. Stewart WA et al. (1986) Magnetic resonance imaging (MRI) in multiple sclerosis (MS): pathological correlation studies in eight cases. Neurology 36: 320.
16. Miller DH, Grossman RI, Reingold SC, McFarland HF. (1998) The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121: 3-24.
17. van Walderveen MAA et al. (1998) Histopathologic correlate of hypointense lesions on T1-weighted spinecho MRI in multiple sclerosis. Neurology 50: 1282-1288.
18. van Waesberghe JHTM et al. (1997) Comparison of four potential MR parameters for severe tissue destruction in multiple sclerosis lesions. Magnetic Resonance Imaging 15: 155-162.
19. Truyen L et al. (1996) Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 47: 1469-1476.
20. O'Riordan JI et al. (1998) T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation. Multiple Sclerosis in press.
21. Rovaris M et al. (1998) Relationship between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology 50: 1601-1608.
22. Barkhof F, McGowan JC, van Waesberghe JHTM, Grossman RI. (1998) Hypointense multiple sclerosis lesions on T1-weighted spin echo magnetic resonance images: their contribution in understanding multiple sclerosis evolution. J Neurol Neurosurg Psychiatry 64 (Suppl): 77-79.
23. Ferguson B, Matyszak MK, Esiri MM, Perry VH. (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120: 393-399.
24. Fu L et al. (1998) Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain 121: 103-113.
25. Trapp BD et al. (1998) Axonal transection in the lesions of multiple sclerosis. N Eng J Med 338: 278-285.
26. Prineas JW, Connell F. (1978) The fine structure of chronically active multiple sclerosis plaques. Neurology 28: 68-75.
27. Losseff NA et al. (1996) Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119: 701-708.
28. Leary SM et al. (1997) Quality assurance for serial studies of spinal cord atrophy. Multiple Sclerosis 3: 279.
29. Losseff NA et al. (1996) Spinal cord atrophy and disability in multiple sclerosis: a serial MRI study. Eur J Neurol 3: (Suppl 4) 2.
30. Kidd D et al. (1993) Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 43: 2632-2637.
31. Stevenson VL et al. (1998) Spinal cord atrophy and disability in MS: A longitudinal study. Neurology 51: 234-238.
32. Fox NC, Freeborough PA, Rossor MN. (1996) Visualisation and quantification of rates of atrophy in Alzheimer's disease.Lancet 348: 94-97.
33. Losseff NA et al. (1996) Progressive cerebral atrophy in multiple sclerosis. A serial study. Brain 119: 2009-2019.
34. Wolff SD, Balaban RS. (1989) Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magnetic Resonance in Medicine 10: 135-144.
35. Dousset V et al. (1992) Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging [published erratum appears in Radiology 1992 Jun; 183(3): 878]. Radiology 182: 483-491.
36. Gass A et al. (1994) Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis.Ann Neurol 36: 62-67.
37. Filippi M et al. (1995) A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 45: 478-482.
38. van Buchem M et al. (1997) Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR 18: 1287-1290.
39. Arnold DL, Matthews PM, Francis G, Antel J. (1990) Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn Reson Med 14: 154-159.
40. Davie CA et al. (1995) Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 118: 1583-1592.
41. 1H magnetic resonance spectroscopy of normal- appearing white matter in primary progressive multiple sclerosis. Ann Neurol 44: 464.
42. Wolinsky JS, Narayana PA, Fenstermacher MJ. (1990) Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 40: 1764-1769.
43. De Stefano N et al. (1995) Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38: 901-909.
44. Arnold DL et al. (1992) Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol 31: 235-241.
45. Arnold DL et al. (1994) Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol 36: 76-82.
46. Horsfield MA, Larsson HBW, Jones DK, Gass A. (1998) Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 64(Suppl): 80-84.
47. Werring DJ et al. (1998) The structural properties of multiple sclerosis (MS) lesions demonstrated hy diffusion tensor imaging. Proceedings of ISMRM 1: 119.
48. Larsson HBW et al. (1992) In vivo magnetic resonance diffusion measurements in the brains of patients with multiple sclerosis. Magnetic Resonance Imaging 10: 7-12.
49. Christiansen P et al. (1993) Increased water self-diffusion in chronic plaques and in apparently normal white matter in patients with multiple sclerosis. Acta Neurol Scand 87: 195-199.